USANA Health Sciences Company Profile (NYSE:USNA)

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences logoUSANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Related Products
  • Sub-Industry: Personal Products
  • Symbol: NYSE:USNA
  • CUSIP: 90328M10
  • Web: www.usanahealthsciences.com
Capitalization:
  • Market Cap: $1.58 billion
  • Outstanding Shares: 24,523,000
Average Prices:
  • 50 Day Moving Avg: $59.91
  • 200 Day Moving Avg: $65.75
  • 52 Week Range: $52.55 - $75.00
P/E:
  • Trailing P/E Ratio: 16.22
  • Foreward P/E Ratio: 13.58
  • P/E Growth: 1.62
Sales & Book Value:
  • Annual Revenue: $1.02 billion
  • Price / Sales: 1.55
  • Book Value: $14.43 per share
  • Price / Book: 4.46
Profitability:
  • EBIDTA: $151.43 million
  • Net Margins: 9.89%
  • Return on Equity: 35.36%
  • Return on Assets: 22.75%
Debt:
  • Current Ratio: 1.93%
  • Quick Ratio: 1.35%
Misc:
  • Average Volume: 167,776 shs.
  • Beta: 1.07
  • Short Ratio: 7.9
 

Frequently Asked Questions for USANA Health Sciences (NYSE:USNA)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings results on Tuesday, May, 2nd. The company reported $0.91 EPS for the quarter, missing analysts' consensus estimates of $0.92 by $0.01. The firm had revenue of $255.32 million for the quarter. USANA Health Sciences had a return on equity of 35.36% and a net margin of 9.89%. View USANA Health Sciences' Earnings History.

When will USANA Health Sciences make its next earnings announcement?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of $3.80-4.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.10. The company issued revenue guidance of $1.04-1.07 billion, compared to the consensus revenue estimate of $1.06 billion.

Where is USANA Health Sciences' stock going? Where will USANA Health Sciences' stock price be in 2017?

2 brokers have issued twelve-month price targets for USANA Health Sciences' shares. Their predictions range from $75.00 to $150.00. On average, they expect USANA Health Sciences' stock price to reach $112.50 in the next twelve months. View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Who owns USANA Health Sciences stock?

USANA Health Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (7.05%), FMR LLC (6.16%), Vanguard Group Inc. (3.82%), Dimensional Fund Advisors LP (2.78%), Schroder Investment Management Group (2.10%) and Nordea Investment Management AB (1.28%). Company insiders that own USANA Health Sciences stock include Dave Wentz, Deborah Woo, Doug Braun, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jerry G Mcclain, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Rick Stambaugh and Robert Auciaux. View Institutional Ownership Trends for USANA Health Sciences.

Who sold USANA Health Sciences stock? Who is selling USANA Health Sciences stock?

USANA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Acadian Asset Management LLC, Schroder Investment Management Group, Spark Investment Management LLC, AQR Capital Management LLC, Hays Advisory LLC, TIAA CREF Investment Management LLC and Acrospire Investment Management LLC. Company insiders that have sold USANA Health Sciences stock in the last year include Dave Wentz, Deborah Woo, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones and Robert Auciaux. View Insider Buying and Selling for USANA Health Sciences.

Who bought USANA Health Sciences stock? Who is buying USANA Health Sciences stock?

USANA Health Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, FMR LLC, Vanguard Group Inc., Goldman Sachs Group Inc., MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Citadel Advisors LLC and Globeflex Capital L P. View Insider Buying and Selling for USANA Health Sciences.

How do I buy USANA Health Sciences stock?

Shares of USANA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of USANA Health Sciences stock cost?

One share of USANA Health Sciences stock can currently be purchased for approximately $64.35.

Analyst Ratings

Consensus Ratings for USANA Health Sciences (NYSE:USNA) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $112.50 (74.83% upside)

Analysts' Ratings History for USANA Health Sciences (NYSE:USNA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/3/2017Pivotal ResearchUpgradeHold -> Buy$55.00 -> $75.00LowView Rating Details
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 -> $150.00N/AView Rating Details
11/4/2015Canaccord GenuityReiterated RatingHold$131.00N/AView Rating Details
10/16/2015SidotiUpgradeNeutral -> Buy$156.00N/AView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for USANA Health Sciences (NYSE:USNA)
Earnings by Quarter for USANA Health Sciences (NYSE:USNA)
Earnings History by Quarter for USANA Health Sciences (NYSE:USNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2017        
5/2/2017Q1 2017$0.92$0.91$255.32 millionViewListenView Earnings Details
2/7/2017Q416$0.94$0.87$253.52 million$252.90 millionViewListenView Earnings Details
10/25/2016Q316$2.13$2.40$263.37 million$254.22 millionViewListenView Earnings Details
7/26/2016Q2$2.05$2.07$256.66 million$258.50 millionViewListenView Earnings Details
5/3/2016Q116$1.81$1.77$244.05 million$240.45 millionViewListenView Earnings Details
2/9/2016Q415$2.00$1.83$250.82 million$232.60 millionViewListenView Earnings Details
11/3/2015Q315$1.76$1.92$230.79 million$233.30 millionViewListenView Earnings Details
8/4/2015Q215$1.60$1.92$211.86 million$233.20 millionViewListenView Earnings Details
5/5/2015Q1$1.30$1.50$198.21 million$219.40 millionViewListenView Earnings Details
2/10/2015Q414$1.93$1.65$219.10 million$227.90 millionViewListenView Earnings Details
10/28/2014Q314$1.37$1.47$190.50 million$191.90 millionViewListenView Earnings Details
7/29/2014Q214$1.50$1.36$198.30 million$188.30 millionViewListenView Earnings Details
4/29/2014Q114$1.30$1.15$185.85 million$182.40 millionViewListenView Earnings Details
2/5/2014Q413$1.22$1.41$175.53 million$186.30 millionViewListenView Earnings Details
10/23/2013Q313$1.14$1.16$172.40 million$173.70 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.33$1.72$176.60 million$189.10 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.16$1.28$171.77 million$169.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$1.21$1.27$165.80 million$168.50 millionViewListenView Earnings Details
10/23/2012$1.06$1.18ViewN/AView Earnings Details
7/24/2012$0.92$1.11ViewN/AView Earnings Details
2/7/2012$0.86$0.87ViewN/AView Earnings Details
10/25/2011$0.76$0.81ViewN/AView Earnings Details
4/26/2011$0.66$0.70ViewN/AView Earnings Details
2/8/2011$0.84$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for USANA Health Sciences (NYSE:USNA)
Current Year EPS Consensus Estimate: $3.95 EPS
Next Year EPS Consensus Estimate: $4.74 EPS

Dividends

Dividend History for USANA Health Sciences (NYSE:USNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for USANA Health Sciences (NYSE:USNA)
Insider Ownership Percentage: 57.00%
Institutional Ownership Percentage: 21.21%
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2017Gilbert A FullerDirectorSell4,884$64.38$314,431.92View SEC Filing  
5/1/2017Myron W WentzDirectorSell40,000$56.39$2,255,600.00View SEC Filing  
4/5/2017Global Ltd GullMajor ShareholderSell16,436$56.54$929,291.44View SEC Filing  
4/5/2017Myron W WentzDirectorSell40,000$56.81$2,272,400.00View SEC Filing  
4/4/2017Global Ltd GullMajor ShareholderSell10,040$56.69$569,167.60View SEC Filing  
4/3/2017Global Ltd GullMajor ShareholderSell13,524$57.22$773,843.28View SEC Filing  
3/8/2017Global Ltd GullMajor ShareholderSell20,000$57.15$1,143,000.00View SEC Filing  
2/8/2017Global Ltd GullMajor ShareholderSell20,000$55.87$1,117,400.00View SEC Filing  
1/11/2017Myron W WentzDirectorSell20,000$61.04$1,220,800.00View SEC Filing  
12/14/2016Myron W WentzDirectorSell20,000$61.41$1,228,200.00View SEC Filing  
11/9/2016Myron W WentzDirectorSell10,000$123.99$1,239,900.00View SEC Filing  
10/12/2016Global Ltd GullMajor ShareholderSell10,000$146.35$1,463,500.00View SEC Filing  
9/14/2016Global Ltd GullMajor ShareholderSell10,000$134.67$1,346,700.00View SEC Filing  
9/8/2016Deborah WooInsiderSell1,058$140.00$148,120.00View SEC Filing  
8/30/2016Paul A JonesCFOSell5,067$138.50$701,779.50View SEC Filing  
8/23/2016Deborah WooInsiderSell2,621$138.94$364,161.74View SEC Filing  
8/23/2016Robert AuciauxDirectorSell2,317$138.79$321,576.43View SEC Filing  
8/19/2016Deborah WooInsiderSell4,590$133.12$611,020.80View SEC Filing  
8/18/2016Deborah WooInsiderSell5,041$131.15$661,127.15View SEC Filing  
8/16/2016James BrambleInsiderSell9,339$131.33$1,226,490.87View SEC Filing  
8/16/2016Jim BrownCOOSell9,104$131.36$1,195,901.44View SEC Filing  
8/15/2016Kevin GuestInsiderSell16,285$131.08$2,134,637.80View SEC Filing  
8/10/2016Global Ltd GullMajor ShareholderSell10,000$135.08$1,350,800.00View SEC Filing  
8/1/2016Gilbert A. FullerDirectorSell859$137.07$117,743.13View SEC Filing  
7/13/2016Global Ltd GullMajor ShareholderSell10,000$118.96$1,189,600.00View SEC Filing  
6/8/2016Global Ltd GullMajor ShareholderSell10,000$123.47$1,234,700.00View SEC Filing  
6/7/2016Dave WentzInsiderSell10,000$125.09$1,250,900.00View SEC Filing  
5/11/2016Global Ltd GullMajor ShareholderSell10,000$122.67$1,226,700.00View SEC Filing  
4/13/2016Global Ltd GullMajor ShareholderSell10,000$121.82$1,218,200.00View SEC Filing  
3/9/2016Myron W WentzDirectorSell10,000$116.07$1,160,700.00View SEC Filing  
3/4/2016Jerry G McclainDirectorSell767$118.17$90,636.39View SEC Filing  
2/24/2016Gilbert A FullerDirectorSell728$113.22$82,424.16View SEC Filing  
2/10/2016Global Ltd GullMajor ShareholderSell10,000$96.37$963,700.00View SEC Filing  
1/13/2016Global Ltd GullMajor ShareholderSell10,000$121.04$1,210,400.00View SEC Filing  
12/17/2015Rick StambaughinsiderSell7,059$130.18$918,940.62View SEC Filing  
12/16/2015Doug BraunCMOSell10,907$130.80$1,426,635.60View SEC Filing  
12/15/2015Dave WentzInsiderSell6,000$130.59$783,540.00View SEC Filing  
12/15/2015Doug BraunCMOSell2,748$132.00$362,736.00View SEC Filing  
12/9/2015Myron W WentzDirectorSell10,000$133.18$1,331,800.00View SEC Filing  
11/11/2015Global Ltd GullMajor ShareholderSell10,000$133.71$1,337,100.00View SEC Filing  
10/1/2015Myron W WentzDirectorSell10,000$131.85$1,318,500.00View SEC Filing  
9/10/2015Myron W WentzDirectorSell7,000$138.32$968,240.00View SEC Filing  
8/27/2015Deborah WooinsiderSell1,527$150.00$229,050.00View SEC Filing  
8/17/2015Paul A JonesCFOSell7,719$162.21$1,252,098.99View SEC Filing  
8/12/2015Myron W WentzDirectorSell7,000$159.84$1,118,880.00View SEC Filing  
7/8/2015Myron W WentzDirectorSell7,000$138.28$967,960.00View SEC Filing  
6/10/2015Myron W WentzDirectorSell7,000$133.75$936,250.00View SEC Filing  
6/9/2015Deborah WooInsiderSell3,656$132.06$482,811.36View SEC Filing  
5/14/2015Deborah WooInsiderSell3,569$124.00$442,556.00View SEC Filing  
5/12/2015Kevin GuestInsiderSell2,858$120.00$342,960.00View SEC Filing  
5/11/2015Daniel A MacugaInsiderSell4,231$125.64$531,582.84View SEC Filing  
5/11/2015Jim BrownCOOSell7,860$124.46$978,255.60View SEC Filing  
4/8/2015Global Ltd GullMajor ShareholderSell7,000$113.54$794,780.00View SEC Filing  
2/12/2015Robert AuciauxDirectorSell5,028$100.18$503,705.04View SEC Filing  
1/14/2015Myron W WentzDirectorSell7,000$101.32$709,240.00View SEC Filing  
12/16/2014Doug BraunCMOSell9,969$101.01$1,006,968.69View SEC Filing  
12/10/2014Myron W WentzDirectorSell102,755$100.25$10,301,188.75View SEC Filing  
12/8/2014Myron W WentzDirectorSell184,245$104.65$19,281,239.25View SEC Filing  
11/3/2014Dave WentzInsiderSell19,780$114.68$2,268,370.40View SEC Filing  
10/31/2014Ronald S PoelmanDirectorSell4,491$112.53$505,372.23View SEC Filing  
10/30/2014Paul A JonesCFOSell10,823$105.10$1,137,497.30View SEC Filing  
10/8/2014Myron W WentzDirectorSell7,000$76.52$535,640.00View SEC Filing  
9/10/2014Myron W WentzDirectorSell7,000$71.53$500,710.00View SEC Filing  
8/25/2014Dave WentzInsiderSell5,141$73.30$376,835.30View SEC Filing  
7/9/2014Myron W WentzDirectorSell7,000$78.95$552,650.00View SEC Filing  
6/13/2014Dave WentzInsiderSell5,301$75.51$400,278.51View SEC Filing  
6/11/2014Myron W WentzDirectorSell7,000$74.69$522,830.00View SEC Filing  
6/10/2014Daniel A MacugaInsiderSell6,654$75.01$499,116.54View SEC Filing  
5/30/2014Deborah WooInsiderSell1,028$73.00$75,044.00View SEC Filing  
5/28/2014Dave WentzInsiderSell5,141$73.03$375,447.23View SEC Filing  
5/28/2014Jerry G McclainDirectorSell1,217$72.12$87,770.04View SEC Filing  
5/22/2014Kevin GuestInsiderSell10,160$71.15$722,884.00View SEC Filing  
5/21/2014Kevin GuestInsiderSell2,475$71.00$175,725.00View SEC Filing  
5/19/2014James BrambleInsiderSell5,919$70.02$414,448.38View SEC Filing  
5/14/2014Myron WentzDirectorSell14,000$73.78$1,032,920.00View SEC Filing  
5/12/2014Deborah WooInsiderSell11,336$70.03$793,860.08View SEC Filing  
5/5/2014Deborah WooInsiderSell3,512$71.00$249,352.00View SEC Filing  
3/4/2014Myron WentzDirectorSell63,805$72.69$4,637,985.45View SEC Filing  
2/11/2014Doug BraunCMOSell8,139$70.46$573,473.94View SEC Filing  
11/13/2013Myron WentzDirectorSell7,000$67.68$473,760.00View SEC Filing  
10/9/2013Holdings Ltd Gullmajor shareholderSell7,000$80.08$560,560.00View SEC Filing  
9/11/2013Deborah WooInsiderSell1,340$79.01$105,873.40View SEC Filing  
9/11/2013Holdings Ltd Gullmajor shareholderSell7,000$78.19$547,330.00View SEC Filing  
9/5/2013Dave WentzInsiderSell13,704$77.93$1,067,952.72View SEC Filing  
9/3/2013Dave WentzInsiderSell32,174$78.10$2,512,789.40View SEC Filing  
8/14/2013Holdings Ltd Gullmajor shareholderSell7,000$80.34$562,380.00View SEC Filing  
8/1/2013Deborah WooInsiderSell1,386$85.00$117,810.00View SEC Filing  
7/26/2013Paul A JonesCFOSell5,047$78.01$393,716.47View SEC Filing  
7/25/2013Kevin GuestInsiderSell19,290$73.20$1,412,028.00View SEC Filing  
7/25/2013Ronald S PoelmanDirectorSell6,380$73.20$467,016.00View SEC Filing  
7/10/2013Holdings Ltd GullMajor ShareholderSell7,000$78.22$547,540.00View SEC Filing  
6/12/2013Holdings Ltd GullMajor ShareholderSell7,000$70.96$496,720.00View SEC Filing  
5/9/2013Robert AuciauxDirectorSell2,664$55.92$148,970.88View SEC Filing  
5/8/2013Holdings Ltd GullMajor ShareholderSell7,000$56.59$396,130.00View SEC Filing  
4/10/2013Holdings Ltd GullMajor ShareholderSell7,000$47.45$332,150.00View SEC Filing  
8/8/2012Myron W WentzDirectorSell7,000$44.21$309,470.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for USANA Health Sciences (NYSE:USNA)
Latest Headlines for USANA Health Sciences (NYSE:USNA)
Source:
DateHeadline
finance.yahoo.com logoUSANA's Rashad Jennings Wins Season 24 of Dancing with The Stars, Captures Mirrorball Trophy with Partner Emma Slater
finance.yahoo.com - May 24 at 8:29 AM
finance.yahoo.com logoGet Serious About Your Bone Health During National Osteoporosis Awareness Month
finance.yahoo.com - May 22 at 8:19 AM
finance.yahoo.com logoUSANA Enjoys Continued Success at Best of State Awards
finance.yahoo.com - May 19 at 1:32 PM
finance.yahoo.com logoGET YOUR SERVICE ON - #USANAgives & you can too
finance.yahoo.com - May 17 at 11:53 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. :USNA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 15, 2017
finance.yahoo.com - May 15 at 7:38 PM
finance.yahoo.com logoEdited Transcript of USNA earnings conference call or presentation 27-Jul-16 3:00pm GMT
finance.yahoo.com - May 14 at 8:01 PM
americanbankingnews.com logoGilbert A. Fuller Sells 4,884 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - May 12 at 1:27 PM
finance.yahoo.com logoUSANA Proudly Celebrates Its 25th Anniversary At Annual Asia-Pacific Convention
finance.yahoo.com - May 8 at 9:19 AM
finance.yahoo.com logoEdited Transcript of USNA earnings conference call or presentation 3-May-17 3:00pm GMT
finance.yahoo.com - May 6 at 12:53 AM
finance.yahoo.com logoUSANA Strengthens Leadership with New Appointments and Roles
finance.yahoo.com - May 6 at 12:53 AM
streetinsider.com logoPivotal Research Upgrades USANA Health Sciences Inc. (USNA) to Buy, Regrets Monday's Downgrade
www.streetinsider.com - May 3 at 11:49 PM
seekingalpha.com logoUSANA Health Sciences Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 3 at 11:49 PM
seekingalpha.com logoUsana: China Uncertainty Means It Should Be Avoided - Seeking Alpha
seekingalpha.com - May 3 at 6:47 PM
streetinsider.com logoPivotal Research Upgrades USANA Health Sciences Inc. (USNA) to Buy, Regrets Monday's Downgrade - StreetInsider.com
www.streetinsider.com - May 3 at 6:47 PM
americanbankingnews.com logoInsider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 40,000 Shares of Stock
www.americanbankingnews.com - May 3 at 3:52 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Announces Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 3 at 12:49 PM
finance.yahoo.com logoUSANA Health posts 1Q profit
finance.yahoo.com - May 3 at 9:59 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Updates FY17 Earnings Guidance
www.americanbankingnews.com - May 2 at 6:58 PM
reuters.com logoBRIEF-USANA Health Sciences Q1 earnings per share $0.91 excluding items
www.reuters.com - May 2 at 6:32 PM
rttnews.com logoUSANA Health Sciences Profit Declines 4% In Q1
www.rttnews.com - May 2 at 6:32 PM
finance.yahoo.com logoUSANA Celebrates Longevity and Success in Malaysia
finance.yahoo.com - May 2 at 6:32 PM
americanbankingnews.com logoPositive Media Coverage Very Likely to Impact USANA Health Sciences (USNA) Share Price
www.americanbankingnews.com - May 2 at 2:40 PM
streetinsider.com logoPivotal Research Downgrades USANA Health Sciences Inc. (USNA) to Hold, "More Clarity Needed" - StreetInsider.com
www.streetinsider.com - May 2 at 8:31 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Receives Hold Rating from Pivotal Research
www.americanbankingnews.com - May 1 at 10:40 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 30 at 8:00 AM
americanbankingnews.com logoUSANA Health Sciences (USNA) Earns News Impact Score of 0.51
www.americanbankingnews.com - April 29 at 11:35 AM
finance.yahoo.com logoUSANA Goes Green For Arbor Day
finance.yahoo.com - April 29 at 12:37 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. – Value Analysis (NYSE:USNA) : April 27, 2017
finance.yahoo.com - April 27 at 10:46 PM
finance.yahoo.com logoUSANA Ranked a Top Revenue Direct Sales Company
finance.yahoo.com - April 27 at 11:53 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : USNA-US : April 26, 2017
finance.yahoo.com - April 26 at 8:27 AM
americanbankingnews.com logoUSANA Health Sciences (USNA) Earns Daily News Impact Score of 0.56
www.americanbankingnews.com - April 24 at 12:39 PM
americanbankingnews.com logoVery Positive Press Coverage Unlikely to Impact USANA Health Sciences (USNA) Stock Price
www.americanbankingnews.com - April 21 at 5:27 PM
americanbankingnews.com logoUSANA Health Sciences (USNA) Receiving Very Favorable Press Coverage, Report Finds
www.americanbankingnews.com - April 18 at 10:25 AM
americanbankingnews.com logoUSANA Health Sciences (USNA) Given Daily Coverage Optimism Score of 0.42
www.americanbankingnews.com - April 15 at 1:46 PM
businesswire.com logoApril 14 Deadline Alert: Law Offices of Howard G. Smith Reminds USANA Health Sciences, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact ...
www.businesswire.com - April 14 at 9:12 AM
finance.yahoo.com logoApril 14 Deadline Alert: Law Offices of Howard G. Smith Reminds USANA Health Sciences, Inc. Investors of Upcoming ... - Yahoo Finance
finance.yahoo.com - April 13 at 10:51 PM
finance.yahoo.com logoDEADLINE ALERT:  Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against USANA Health Sciences, Inc. (USNA) & Lead Plaintiff Deadline - April 14, 2017
finance.yahoo.com - April 13 at 10:51 PM
finance.yahoo.com logoApril 14 Deadline Alert: Law Offices of Howard G. Smith Reminds USANA Health Sciences, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm
finance.yahoo.com - April 13 at 10:51 PM
finance.yahoo.com logoDEADLINE ALERT: Levi & Korsinsky, LLP Reminds Shareholders of USANA Health Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 14, 2017 - USNA
finance.yahoo.com - April 13 at 10:51 PM
finance.yahoo.com logoDEADLINE TOMORROW: Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - April 13 at 10:51 PM
finance.yahoo.com logoGet Yourself Marathon Ready with These Six Expert Training Tips
finance.yahoo.com - April 13 at 10:51 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 12 at 2:22 PM
finance.yahoo.com logoFive Small-Caps For The Long-Term Investor
finance.yahoo.com - April 12 at 12:05 PM
finance.yahoo.com logoFRIDAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - April 10 at 7:59 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against USANA Health Sciences, Inc. - USNA
finance.yahoo.com - April 10 at 7:59 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of USANA Health Sciences, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - April 10 at 7:59 PM
finance.yahoo.com logoONE WEEK DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - April 7 at 11:19 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - April 7 at 1:16 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In USANA Health Sciences, Inc. To Contact The Firm
finance.yahoo.com - April 7 at 1:16 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against USANA Health Sciences, Inc. (USNA) and Lead Plaintiff Deadline - April 14, 2017
finance.yahoo.com - April 7 at 1:16 PM

Social

Chart

USANA Health Sciences (USNA) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff